Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14751 - 14775 of 14838 in total
PF-4191834 has been investigated for the basic science of Asthma.
Investigational
Vestipitant has been investigated for the treatment of Tinnitus.
Investigational
Investigational
Experimental
ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant reductions in LDL-cholesterol.
Investigational
Experimental
Investigational
Experimental
Displaying drugs 14751 - 14775 of 14838 in total